Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-20. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Drug carriers: Carriers such as "Trojan horse" molecules, liposomes, and nanoparticles might theoretically allow a therapeutic drug to enter the brain. Such tactics are mostly in the investigatory stages and are not yet clinically relevant to brain tumour treatment.
A referendum of the mostly white electorate approved the new constitution by a majority of 65% on 26 July 1961. The final version of the constitution included a few extra provisions inserted by the British, one of which—Section 111—reserved full powers to the Crown to amend, add to or revoke certain sections of the Southern Rhodesian constitution by Order in Council at the request of the British government. This effectively negated the relinquishment of British powers described elsewhere in the document, but the Southern Rhodesians did not initially notice it. The black Rhodesian movement in Southern Rhodesia, founded and organised by urban black elites during the late 1950s, was repeatedly banned by the colonial government because of the political violence, industrial sabotage and intimidation of potential black voters that characterised its campaign. The principal nationalist group, led by the Bulawayo trade unionist Joshua Nkomo, renamed itself with each post-ban reorganisation, and by the start of 1962 was called the Zimbabwe African People's Union (ZAPU). Attempting to win black political support, Whitehead proposed a number of reforms to racially discriminatory legislation, including the Land Apportionment Act, and promised to implement these if his UFP won the next Southern Rhodesian election. Intimidation by ZAPU of prospective black voters impeded the UFP's efforts to win their support and caused low turnout, but regardless, the UFP won 14 of 15 primarily black seats in the December 1962 Southern Rhodesian election.
To guarantee policies that secure women's rights, the Lula government created, on 8 March, the International Women's Day, numerous actions and measures for this purpose. One of the measures was the Equal Pay Bill, which requires companies to be more transparent and strengthen inspection and combat wage discrimination between women and men. On 4 April, Lula decreed that Women's police stations would be open 24/7, even on holidays; another measure was also made, with the objective of fighting sexual harassment in public agencies and private institutions that provide services to the government.
=== NOP cellular signalling partners === Like most G-protein coupled receptors, NOP signals through canonical G proteins upon activation. G proteins are heterotrimeric complexes consisting of α, β, and γ subunits. NOP signals through a variety of Gα subtypes that trigger diverse downstream signaling cascades. NOP coupling to Gαi or Gαo subunits leads to an inhibition of adenylyl cyclase (AC) causing an intracellular decrease in cyclic adenosine monophosphate(cAMP) levels, an important second messenger for many signal transduction pathways. NOP acting through Gαi/o pathways has also been shown to activate Phospholipase A2 (PLA2), thereby initiating Mitogen-activated protein kinase (MAPK) signaling cascades. In contrast to classical OPs, NOP also couples to Pertussis toxin (PTX)-insensitive subtypes Gαz, Gα14, and Gα16, as well as potentially to Gα12 and Gαs. Activation of NOP's canonical β-arrestin pathway causes receptor phosphorylation, internalization, and eventual downregulation and recycling. NOP activation also causes indirect inhibition of opioid receptors MOP and KOP, resulting in anti-opioid activity in certain tissues. Additionally, NOP activation leads to the activation of potassium channels and inhibition of calcium channels which collectively inhibit neuronal firing.
In 1874 Jacobus Henricus van 't Hoff and Joseph Le Bel independently proposed the tetrahedral arrangement of the atoms bound to carbon in organic molecules. Van't Hoff's theory validated and explained Pasteur's results with tartrate crystals, and Johannes Wislicenus' work with isomeric lactic acids, and was fundamental to the further development of stereochemistry. Until the use of X-rays there was no way to determine the actual crystal structure of even the simplest substances such as salt (NaCl). For example in the 1880s, William Barlow proposed several crystal structures based on close-packing of spheres some of which were validated later by X-ray crystallography; however, the available data were too scarce in the 1880s to accept his models as conclusive. In the period between the discovery of X-rays (1895) and X-ray diffraction (1912) Barlow and William Jackson Pope developed the principles of packing, and showed how to deduce the structures of some simple compounds. In the 1930s Linus Pauling was impressed that Barlow had assigned many crystal structures of metals (copper, silver, and gold to cubic close packing, and magnesium, zinc, and cadmium to hexagonal close packing) and salts (sodium, potassium and caesium chlorides) which were subsequently proved to be correct by X-ray crystallography. William Johnson Sollas emphasised the importance of different atomic sizes in constructing simple crystals, and correctly concluded that the sodium and chlorine atoms in salt would be of different sizes.
Sources: en.wikipedia.org
Mutations alter an organism's genotype and occasionally this causes different phenotypes to appear. Most mutations have little effect on an organism's phenotype, health, or reproductive fitness. Mutations that do have an effect are usually detrimental, but occasionally some can be beneficial. Studies in the fly Drosophila melanogaster suggest that if a mutation changes a protein produced by a gene, about 70 percent of these mutations are harmful with the remainder being either neutral or weakly beneficial.
=== Growth === By 1970, Millipore had established subsidiaries in seven countries. The company opened manufacturing plants in Jaffrey, New Hampshire; Molsheim, France; County Cork, Ireland; and other locations. Millipore's 2006 acquisition of Serologicals Corporation provided entry to high-growth markets for drug discovery products and services, antibodies, cell biology reagents, and stem cell research. As of the late 2000s, Millipore was the only company providing both upstream cell culture and downstream separations offerings for biopharmaceutical production.
=== Speed and simplicity === Time to obtain the test result is a key driver for these products. Tests results can be available in as little as a few minutes. Generally there is a trade off between time and sensitivity: more sensitive tests may take longer to develop. The other key advantage of this format of test compared to other immunoassays is the simplicity of the test, by typically requiring little or no sample or reagent preparation.
The Lipoprotein Insulin Resistance Index (LP-IR) test is a blood test that measures insulin resistance using a composite score derived from lipoprotein particle sizes and concentrations. It is performed using nuclear magnetic resonance (NMR) spectroscopy, which analyzes six specific lipoprotein parameters in a blood sample:
Jerusalem artichokes were first cultivated by the Indigenous peoples of the Americas, though the exact native range of the species is unknown. Genome analysis has ruled out the common sunflower (also originating in the Americas) as an ancestor, and instead points to hybridization between the hairy sunflower and the sawtooth sunflower. The French explorer Samuel de Champlain discovered that the native people of Nauset Harbor in Massachusetts had cultivated roots that tasted like artichoke. The following year, Champlain returned to the same area to discover that the roots had a flavor similar to chard and was responsible for bringing the plant back to France. Sometime later, Petrus Hondius, a Dutch botanist, planted a shriveled Jerusalem artichoke tuber in his garden at Terneuzen and was surprised to see the plant proliferate. Jerusalem artichokes are so well-suited for the European climate and soil that the plant multiplies quickly. By the mid-1600s, the Jerusalem artichoke had become a very common vegetable for human consumption in Europe and the Americas and was also used for livestock feed in Europe and colonial America. The French were particularly fond of the vegetable, which reached its peak popularity at the turn of the 19th century. The Jerusalem artichoke was titled 'best soup vegetable' in the 2002 Nice Festival for the Heritage of French Cuisine.
Sources: en.wikipedia.org
Autosomal dominant: heart problems with weakness (and wasting) of skeletal muscles and Achilles tendon contractures. X-linked: result of the EMD gene mutation, characterized by cardiac involvement. Autosomal recessive: characterized by cardiac issues, such as arrhythmia.
By late 2019, disagreements emerged within Pakatan Harapan about Mahathir's planned handover of power to Anwar Ibrahim, eventually culminating in a political crisis in 2020. Mahathir and a faction of the coalition felt that Anwar would be unable to command a parliamentary majority. MPs supporting Anwar demanded a timeframe for Mahathir's resignation and handover of power. In February 2020, MPs opposed to Anwar taking over met and agreed to form a new government. Anwar told the media that he had been "betrayed". Anwar and Mahathir met to clarify the situation, where Mahathir insisted he had no involvement in a new government. Mahathir, refusing to work with UMNO leaders, submitted his resignation to the Agong, Abdullah of Pahang, on 24 February 2020. The Agong appointed him interim prime minister until a replacement could be agreed. BERSATU President Muhyiddin Yassin declared the party's withdrawal from Pakatan Harapan; Mahathir also resigned from the party in response. The next day, Mahathir reported to work as usual in his new role as caretaker prime minister. During his interim premiership, he introduced the 2020 Economic Stimulus Package to counter the economic impact of COVID-19, based on three strategies: mitigating its impact, spurring people-centric economic growth, and promoting quality investments. On 29 February, the Agong appointed Muhyiddin prime minister, determining that he was most likely to be able to hold the support of a majority in parliament.
Information published by the Department for Science, Innovation and Technology reveals that £15,000 in damages was paid to academic Kate Sand after Science Minister Michelle Donelan described her as a Hamas supporter in 2023; Donelan retracted the allegations on 5 March. University Challenge contestant Melika Gorgianeh accepts substantial damages from Conservative peer Jacqueline Foster after Foster accused her of being antisemitic following her appearance on the quiz show in November 2023. Senedd member Rhys ab Owen is to be banned from the Senedd for six weeks after an investigation by the Senedd Commission found he inappropriately touched two women during a night out in June 2021. 7 March – Blur drummer Dave Rowntree is selected as the Labour Party candidate for Mid Sussex. 8 March – Former prime minister Theresa May announces she is stepping down from Parliament at the next general election. Brenda Dacres is elected Mayor of Lewisham becoming the first black woman directly elected mayor in England. Robin Simcox, the UK government's Commissioner for Countering Extremism, warns that London has become a "no-go zone for Jews" at weekends because of pro-Palestinian protests. 9 March – In an article posted on LinkedIn, senior UK government ministers Anne-Marie Trevelyan and Tom Tugendhat urge Sunak to increase defence spending to above 2.5% of GDP, arguing that the UK needs to "lead the way" on defence spending and invest at a "much greater pace".
=== Marine toxicity === Plutonium is known to enter the marine environment by dumping of waste or accidental leakage from nuclear plants. Though the highest concentrations of plutonium in marine environments are found in sediments, the complex biogeochemical cycle of plutonium means it is also found in all other compartments. For example, various zooplankton species that aid in the nutrient cycle will consume the element on a daily basis. The complete excretion of ingested plutonium by zooplankton makes their defecation an extremely important mechanism in the scavenging of plutonium from surface waters. However, those zooplankton that succumb to predation by larger organisms may become a transmission vehicle of plutonium to fish. In addition to consumption, fish can also be exposed to plutonium by their distribution around the globe. One study investigated the effects of transuranium elements (plutonium-238, plutonium-239, plutonium-240) on various fish living in the Chernobyl Exclusion Zone (CEZ). Results showed that a proportion of female perch in the CEZ displayed either a failure or delay in maturation of the gonads. Similar studies found large accumulations of plutonium in the respiratory and digestive organs of cod, flounder and herring. Plutonium toxicity is just as detrimental to larvae of fish in nuclear waste areas. Undeveloped eggs have a higher risk than developed adult fish exposed to the element in these waste areas.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.